FDA Inspection 1034986 — Direct Rx
The FDA completed an inspection of Direct Rx on December 15, 2017 in Dawsonville, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 15, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dawsonville, GA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 3640 | 21 CFR 211.204 | Returned drug products identified and held |